Brooke Sutherland, Columnist

Spurned AmSurg Finds New Love Is the Best Revenge

Envision's probably a better target than Team Health, now left in the cold.

June 9, 2016 at 3:23 PM UTC

Brooke Sutherland is Bloomberg News' Boston bureau chief and writes the Industrial Strength Newsletter. She was previously a Bloomberg Opinion columnist covering deals and industrial companies and an M&A reporter for Bloomberg News.

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Moving on is the best revenge for surgical-center operator AmSurg.

The $4.4 billion company is reportedly in talks to merge with Envision Healthcare, a provider of physician services that's both bigger and arguably better than AmSurg's last beau, Team Health. AmSurg made two cash-and-stock offers for Team Health last year, both of which were rejected as too low. The latest proposal valued Team Health at $69.32 a share; it's now trading at about $45 after plunging as much as 7.7 percent on news of AmSurg's alternative deal.